Interleukin-4 Gene Polymorphism is not Involved in the Risk of Recurrent Pregnancy Loss
Version of Record online: 26 JUL 2004
American Journal of Reproductive Immunology
Volume 52, Issue 2, pages 143–146, August 2004
How to Cite
Saijo, Y., Sata, F., Yamada, H., Konodo, T., Kato, E. H., Kataoka, S., Shimada, S., Morikawa, M., Minakami, H. and Kishi, R. (2004), Interleukin-4 Gene Polymorphism is not Involved in the Risk of Recurrent Pregnancy Loss. American Journal of Reproductive Immunology, 52: 143–146. doi: 10.1111/j.1600-0897.2004.00193.x
- Issue online: 26 JUL 2004
- Version of Record online: 26 JUL 2004
- Submitted March 1, 2004; revised April 21, 2004; accepted May 3, 2004.
- recurrent pregnancy loss
Problem: Enhanced secretion of type-2 T-helper (Th2) cytokine is a characteristic feature in normal physiological pregnancy. A study has demonstrated defective production of interleukine-4 (IL-4) and other Th2 cytokine in women with recurrent pregnancy loss (RPL). Several studies have suggested that IL-4 variable number of tandem repeat (VNTR) gene polymorphism is probably associated with different IL-4 production.
Methods of study: The IL-4 VNTR genotypes were assessed in 109 Japanese women with RPL and 210 ethnically matched women experiencing at least one live birth and no spontaneous abortion.
Results: No significant differences in IL-4 VNTR genotype frequencies were found between the RPL and the control [B1B1 genotype (reference); B1/B2 and B2/B2 genotypes, odds ratio, 0.91; 95% confidence interval, 0.58–1.45].
Conclusion: The present study suggests that the IL-4 VNTR allele is not a major genetic regulator in RPL.